http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-198720-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D243-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41 |
| filingDate | 1983-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8de0dbb630957285c89517476c41660 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99f5c6745cfab8db435ebe9479aa71e7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_943cc492eafa1bd8dcc8e7d276494acf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f11378f0e392b586ce328ae03ac94bc3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d75e4c48871ac679218978e14ecd08e0 |
| publicationDate | 1989-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | HU-198720-B |
| titleOfInvention | Process for producing pyridazodiazepines and pharmaceutical compositions containing them |
| abstract | Bicyclo-diaza-heterocycles of formula (I) and their salts are new (B is methylene, ethylene or vinylene. R1 is H or alkyl (opt. substd. by aryl; amino (itself opt. substd. by 1 or 2 alkyl); acylamino; phthalimido; alkoxy-, aryloxy- or aralkoxy-carbonylamino; alkyl-, aryl- or aralkyl- aminocarbonylamino; or alkyl- or aryl-sulphonylamino). R2 is carboxy, alkoxycarbonyl, aralkoxycarbonyl, -PO(OH)2 or -CONR6R7. R3 is carboxy, alkoxycarbonyl or aralkoxycarbonyl. R4 and R5 are both H or together form oxo. R6 and R7 are H, alkyl, aralkyl or together complete a satd., 5 or 6 membered heterocycle, opt. contg. an additional N, O or S atom. n is 0-2). (I) are antihypertensives (inhibitors of angistension-converting enzyme). They are formulated conventionally for oral or parenteral administration, pref. at daily doses of 1-50 mg per kg.. |
| priorityDate | 1983-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 78.